Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

import-guides

  1. Home>
  2. News>
  3. import-guides>
  4. Page 3

How to Verify Legitimate Indian Generic Medicine Suppliers: A 2026 Buyer’s Guide

  • Post published:July 16, 2026
  • Post category:Knowledge

The global demand for Indian generic medicines continues to surge in 2026, driven by India's position as the "Pharmacy of the World" — supplying over 20% of the world's generic…

Continue Reading How to Verify Legitimate Indian Generic Medicine Suppliers: A 2026 Buyer’s Guide

Understanding India’s Pharmaceutical Export Certification: A 2026 Buyer’s Guide

  • Post published:June 27, 2026
  • Post category:Knowledge

India, often called the "Pharmacy of the World," supplies over 20% of the global market for generic medicines and exports pharmaceutical products to more than 200 countries. However, for international…

Continue Reading Understanding India’s Pharmaceutical Export Certification: A 2026 Buyer’s Guide

India’s Generic Medicine Supply Chain: NITI Aayog Warns of Critical Chinese API Dependence

  • Post published:June 24, 2026
  • Post category:Knowledge

India’s pharmaceutical industry supplies roughly 40 percent of the United States’ generic medicines and approximately 20 percent of global demand. Yet behind this impressive export footprint lies a structural vulnerability…

Continue Reading India’s Generic Medicine Supply Chain: NITI Aayog Warns of Critical Chinese API Dependence

India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform

  • Post published:June 22, 2026
  • Post category:Knowledge

June 2026 marks a pivotal moment for India's generic pharmaceutical industry. From landmark shifts toward women's health therapeutics to explosive growth in the generic GLP-1 market and sweeping drug-quality reforms,…

Continue Reading India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page

Recent Posts

  • iPHEX 2026: 600+ Global Delegates Set to Source from India’s Pharma Sector
    September 4, 2026/
    0 Comments
  • WHO-GMP Certification for Indian Generic Medicines: A 2026 Buyer’s Complete Guide
    September 3, 2026/
    0 Comments
  • CDSCO Orders Pharma Firms to Maintain ADR Reporting Systems
    September 2, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • iPHEX 2026: 600+ Global Delegates Set to Source from India’s Pharma Sector
  • WHO-GMP Certification for Indian Generic Medicines: A 2026 Buyer’s Complete Guide
  • CDSCO Orders Pharma Firms to Maintain ADR Reporting Systems
  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve